Sickle Cell Disease

Predictive Ability of Intermittent Pain Diaries in Sickle Cell Disease

Predictive Ability of Intermittent Pain Diaries in Sickle Cell Disease

By

In patients with sickle cell disease, review of intermittent pain diaries using a single random day per week or a single week per month was shown to be comparable to review of 5 months' worth of pain diaries.

New Sickle Cell Disease Treatment Gets FDA Approval

New Sickle Cell Disease Treatment Gets FDA Approval

By

The FDA has approved Endari to reduce acute complications of sickle cell disease in patients aged ≥5 years.

Diagnostic Criteria for Chronic Sickle Cell Disease-Related Pain

Diagnostic Criteria for Chronic Sickle Cell Disease-Related Pain

By

A new evidence-based classification system for chronic sickle cell disease pain was recently published.

Treatment May Alleviate Sickle Cell-Related Pain

Treatment May Alleviate Sickle Cell-Related Pain

Crizanlizumab therapy resulted in a significantly lower rate of sickle cell-related pain crises.

Sign Up for Free e-Newsletters